Category: Blood Diseases
Blood Diseases market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Hemophilia a Gene Therapies
The 2025-2030 World Outlook for Hemophilia a Gene Therapies This study covers the world outlook for hemophilia a gene therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Hemophilia a Treatments
The 2025-2030 World Outlook for Hemophilia a Treatments This study covers the world outlook for hemophilia a treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Hemophilia Drugs
The 2025-2030 World Outlook for Hemophilia Drugs This study covers the world outlook for hemophilia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Hematological Disorder Drugs and Diagnostics
The 2025-2030 World Outlook for Hematological Disorder Drugs and Diagnostics This study covers the world outlook for hematological disorder drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Bleeding Disorder Drugs
The 2025-2030 World Outlook for Bleeding Disorder Drugs This study covers the world outlook for bleeding disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Thalassemia Treatments
The 2025-2030 World Outlook for Thalassemia Treatments This study covers the world outlook for thalassemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Blood Plasma Fractionation
The 2025-2030 World Outlook for Blood Plasma Fractionation This study covers the world outlook for blood plasma fractionation across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Renal Anemia Treatments
The 2025-2030 World Outlook for Renal Anemia Treatments This study covers the world outlook for renal anemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Hemophilia
The 2025-2030 World Outlook for Hemophilia This study covers the world outlook for hemophilia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
-
The 2025-2030 World Outlook for Hemophilia a Drugs
The 2025-2030 World Outlook for Hemophilia a Drugs This study covers the world outlook for hemophilia a drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Blood Cancer Therapeutics
The 2025-2030 World Outlook for Blood Cancer Therapeutics This study covers the world outlook for blood cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Anemia Drugs
The 2025-2030 World Outlook for Anemia Drugs This study covers the world outlook for anemia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the ... Read More
-
The 2025-2030 World Outlook for Hemophilia Gene Therapies
The 2025-2030 World Outlook for Hemophilia Gene Therapies This study covers the world outlook for hemophilia gene therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Immune Thrombocytopenia
The 2025-2030 World Outlook for Immune Thrombocytopenia This study covers the world outlook for immune thrombocytopenia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Hydroxyurea Sickle Cell Disease Treatments
The 2025-2030 World Outlook for Hydroxyurea Sickle Cell Disease Treatments This study covers the world outlook for hydroxyurea sickle cell disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Iron Deficiency Anemia Drugs
The 2025-2030 World Outlook for Iron Deficiency Anemia Drugs This study covers the world outlook for iron deficiency anemia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Von Willebrand Disease Treatments
The 2025-2030 World Outlook for Von Willebrand Disease Treatments This study covers the world outlook for Von Willebrand disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Rare Hemophilia Factors
The 2025-2030 World Outlook for Rare Hemophilia Factors This study covers the world outlook for rare hemophilia factors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Oral Iron Therapy for Iron Deficiency Anemia
The 2025-2030 World Outlook for Oral Iron Therapy for Iron Deficiency Anemia This study covers the world outlook for oral iron therapy for iron deficiency anemia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Plasma Fractionation
The 2025-2030 World Outlook for Plasma Fractionation This study covers the world outlook for plasma fractionation across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Sickle Cell Anemia Treatments
The 2025-2030 World Outlook for Sickle Cell Anemia Treatments This study covers the world outlook for sickle cell anemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Hemophilia Treatments
The 2025-2030 World Outlook for Hemophilia Treatments This study covers the world outlook for hemophilia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Iron Deficiency Anemia Therapies
The 2025-2030 World Outlook for Iron Deficiency Anemia Therapies This study covers the world outlook for iron deficiency anemia therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Rare Hematology Plasma-Derived Factors
The 2025-2030 World Outlook for Rare Hematology Plasma-Derived Factors This study covers the world outlook for rare hematology plasma-derived factors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Haemoglobinopathies
The 2025-2030 World Outlook for Haemoglobinopathies This study covers the world outlook for haemoglobinopathies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
Research Assistance
